Abstracts

Cabotegravir and Rilpivirine As 2-Drug Oral Maintenance Therapy: LATTE W96 Results

Background: Cabotegravir (CAB, GSK744) is an HIV INSTI under development as both an oral and long-acting (LA) injectable. LATTE was designed to select an oral dose of CAB and to evaluate a two-drug ART regimen with rilpivirine (RPV), as suppressive maintenance therapy. Methods: Phase 2b, multicentre, partially-blinded, dose-ranging study in ART-naïve HIV infected adults, randomized…

Self-Reported Versus Blood-Tested ART Intake to Estimate ART Coverage in South Africa

Background: Reliable information on ART intake is essential to estimate ART coverage and interpret HIV resistance. In the context of a population-based HIV survey in Mbongolwane and Eshowe, KwaZulu-Natal, South Africa, we assessed self-reported versus blood-tested ART intake agreement and we estimated ART coverage using both measurements. Methods: Cross-sectional population-based survey. Persons aged 15-59 years…

Real-Time Electronic Adherence Monitoring and Risk of Viral Rebound

Background: While sustained adherence to antiretroviral therapy (ART) is known to be critical for viral suppression, the risk of viral rebound associated with any given adherence interruption is poorly understood. We used real-time adherence monitoring and HIV RNA measurement during adherence interruptions to understand the characteristics of interruptions that predict viral rebound. Methods: The Ugandan…

Determinants of Adherence to Antiretroviral Therapy Differ Between Africa and Asia

Background: Adherence to antiretroviral therapy (ART) has been poorly studied among HIV-infected populations in resource-limited settings. We studied determinants of adherence in sub-Saharan Africa and Asia. Methods: In a cohort collaboration in Africa (6 countries, 13 sites) and Asia (5 countries, 11 sites) adherence was assessed using the WHO-validated Adherence Visual Analogue Scale (VAS) at…

Retention on Antiretroviral Therapy by Sex and Pregnancy Status in a Large Cohort of HIV-Infected Patients in Rural Nigeria

Background: To examine whether differences exist in retention on antiretroviral therapy (ART) by sex and pregnancy status in a cohort of HIV-infected patients enrolled in a HIV treatment program in rural north-central Nigeria. Methods: We used routine program data collected from June 2009–September 2013. The study population included HIV-infected ART-naïve patients entering care and treatment…

Randomised Controlled Trial of Text-Message Dosing Reminders in Patients Starting ART

Background: Some studies have shown that antiretroviral therapy (ART) adherence could be improved with mobile phone text message reminders, while other studies have shown that patients rapidly habituate to reminders. We hypothesized that text message reminders, sent only when dosing is late, as recorded by real-time electronic adherence monitoring devices (EAMD), would improve adherence and…

Socioeconomic Factors and Virological Rebound: A Prospective UK Cohort Study

Background: Little is known about the effect of social deprivation on HIV treatment outcomes in the UK, a setting with universal free access to health care. We assessed the association of socio-economic factors with subsequent virological rebound among individuals with initial virological suppression on ART. Methods: ASTRA is a questionnaire study of 3258 HIV-diagnosed individuals…

Monitoring and Switching of Antiretroviral Therapy in Sub-Saharan Africa

Background: Monitoring of antiretroviral combination therapy (ART) aims to maximize the durability of first-line ART regimens. Viral load monitoring is recommended but limited access to viral load tests in resource-limited settings means that decisions about switching to second-line ART are often based on clinical or immunological criteria. We examined monitoring of ART and switching to…